???pagination.result.count???
???pagination.result.page???
1
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery. , O'Connor EC., Expert Opin Drug Discov. February 1, 2024; 19 (2): 173-187.
A convergent molecular network underlying autism and congenital heart disease. , Rosenthal SB., Cell Syst. November 17, 2021; 12 (11): 1094-1107.e6.
An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups. , Perszyk R., Elife. May 24, 2018; 7
MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit. , Volkmann RA., PLoS One. January 1, 2016; 11 (2): e0148129.
GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine. , Pierson TM., Ann Clin Transl Neurol. March 1, 2014; 1 (3): 190-198.
PSD-95 and PKC converge in regulating NMDA receptor trafficking and gating. , Lin Y., Proc Natl Acad Sci U S A. December 26, 2006; 103 (52): 19902-7.
K(+) occupancy of the N-methyl-d-aspartate receptor channel probed by Mg(2+) block. , Zhu Y., J Gen Physiol. March 1, 2001; 117 (3): 287-98.
Na(+) occupancy and Mg(2+) block of the n-methyl-d-aspartate receptor channel. , Zhu Y., J Gen Physiol. March 1, 2001; 117 (3): 275-86.